Telemedicine to Enhance Adherence to Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Syndrome; a Randomized Placebo-controlled Prospective Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnea Syndrome
- Sponsor
- Otto D. Schoch
- Enrollment
- 240
- Locations
- 1
- Primary Endpoint
- Proportion of nights with CPAP use (defined as ≥1h of CPAP use per night within the last month including nights of no-use of CPAP) at 6 months
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
We hypothesize that the use of telemedicine combined with support interventions by short messages, telephone calls and ambulatory visits to control CPAP treatment during the first month improves adherence and reduces unresolved side effects of therapy.
The primary objective of an OSAS treatment program is to successfully implement indicated CPAP in the highest possible proportion of patients in order to lower the proportion of untreated OSAS in the population. On an individual basis, it has been shown that a longer duration of CPAP use is associated with better outcomes in terms of daytime functioning and in the control of metabolic and blood pressure effects of CPAP. For our study, we have therefore decided to use 2 co-primary endpoints, taking into account both aspects of adherence mentioned. Cardiovascular complications are a major concern in OSAS patients. Effective CPAP treatment has been shown to reduce surrogate measures of cardiovascular risk. We hypothesize that intensified efforts for CPAP adherence with telemedicine has a positive impact on a number of surrogate measures of the cardiovascular risk at 1 and 6 months of treatment.
Investigators
Otto D. Schoch
Sponsor investigator
Cantonal Hospital of St. Gallen
Eligibility Criteria
Inclusion Criteria
- •Symptomatic OSAS patients with an AHI and an oxygen desaturation index (ODI) of \>5/h in polysomnography (PSG) consenting to start longterm CPAP treatment.
Exclusion Criteria
- •Age \<18 years
- •Unable to communicate in German, English, French or Italian
- •Alcohol consumption \> 4 units \>4 times a week
- •Acute manifestation of psychiatric diseases
- •Life expectancy of \< 6 months for any reason
- •Surgical obesity treatment planned within the next 6 months
- •Predominantly Central sleep apnea and cheyne stokes respiration
Outcomes
Primary Outcomes
Proportion of nights with CPAP use (defined as ≥1h of CPAP use per night within the last month including nights of no-use of CPAP) at 6 months
Time Frame: at 6 months
Secondary Outcomes
- Average nightly use of CPAP during the first 6 months of treatment (minutes per night including nights of no-use of CPAP since day 1)(at 6 months)